|
AMED
|
Amedisys Inc
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DRRX
|
DURECT Corporation
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
|
EYPT
|
EyePoint Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
OTRK
|
Ontrak, Inc.
|
US
|
NASDAQ
|
|
PHGE
|
BiomX Inc.
|
US
|
AMEX
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
SGTX
|
Sigilon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SMLR
|
Semler Scientific, Inc.
|
US
|
NASDAQ
|
|
TCMD
|
Tactile Systems Technology, Inc.
|
US
|
NASDAQ
|
|
UNH
|
UnitedHealth Group Incorporated
|
US
|
NYSE
|
|
VANI
|
Vivani Medical, Inc.
|
US
|
NASDAQ
|
|
ADR
|
Adherium Ltd
|
AU
|
ASX
|
|
ATX
|
Amplia Therapeutics Limited
|
AU
|
ASX
|
|
EVE
|
Eve Investments Ltd
|
AU
|
ASX
|
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
|
JDHIF
|
Jd Health Intl Inc
|
US
|
OTC
|
|
PTCHF
|
PureTech Health plc
|
US
|
OTC
|
|
RSMDF
|
Resmed Inc
|
US
|
OTC
|